Expertise in
5
conditions

Ingrid Glimelius

Uppsala, C, SE 
Expertise in
5
conditions
Uppsala, C, SE 

Overview

Ingrid Glimelius practices practicing medicine in Uppsala, Sweden.

Ms. Glimelius is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Hodgkin Lymphoma, Classical Hodgkin Lymphoma, and Non-Hodgkin Lymphoma.

She is actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Uppsala, C, Sweden
Other Locations
Solna, AB, Sweden
Karolinska Institutet
Stockholm, AB, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2024
Intervention Type: Drug
Study Drug: Acalabrutinib-Rituximab
Study Phase: Phase 2
Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Enrollment Status: Unknown
Publish Date: October 13, 2021
Intervention Type: Drug
Study Drug: Venetoclax
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

130 Total Publications

No association between temozolomide maintenance and survival after first-line treatment in primary CNS lymphoma.
No association between temozolomide maintenance and survival after first-line treatment in primary CNS lymphoma.
Journal: HemaSphere
Published: May 21, 2026

Frequently Asked Questions about Ingrid Glimelius

Is Ingrid Glimelius a top-rated expert for Mantle Cell Lymphoma (MCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Ingrid Glimelius is classified as an Elite expert for Mantle Cell Lymphoma (MCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ingrid Glimelius participate in research or clinical trials?

Yes. Ingrid Glimelius has published 130 articles and abstracts on conditions like Mantle Cell Lymphoma (MCL). You can view a list of Ingrid Glimelius's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Glimelius's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile